Parkinson’s

  • Aspen Neuroscience receives FDA RMAT designation for Parkinson’s candidate

    A Parkinson’s cell therapy has gained FDA RMAT designation, giving its development programme access to closer regulatory guidance. The US Food and Drug Administration granted the designation to sasineprocel, also known as ANPD001, Aspen Neuroscience’s lead experimental treatment for Parkinson’s disease. Regenerative Medicine Advanced Therapy designation provides increased FDA guidance and support intended to speed [...]

  • Parkinson’s pensioner prosecuted for unpaid £3.34 car bill

    A pensioner with Parkinson's disease, 86, has been convicted in a fast-track court over an unpaid vehicle tax bill of £3.34. The man, who lives on the outskirts of Newcastle, told the court about his health difficulties and that his wife, also 86, has Alzheimer’s disease. He explained that the annual £20 tax bill for [...]

  • Friends raise £5k for Parkinson’s research

    Two young women have raised more than £5,000 for Parkinson’s research after cycling 400 miles from Norfolk to South Wales. PE teacher Alice Collins and driving instructor Laura Nicholls, both 26, set off from Mattishall on the morning of 23 July and arrived in Tenby four days later. The route took them through Ely and [...]

  • Table tennis could improve balance in Parkinson’s patients – study

    A 12-week table tennis programme may improve movement, balance and walking endurance in people with Parkinson’s, a small pilot study suggests. Participants were able to walk further after completing the NeuroPong programme and reported fewer symptoms of depression than at the start. The programme combines table tennis instruction with exercises tailored to people with Parkinson’s. [...]

  • New partnership aims to accelerate Parkinson’s stem cell therapies

    A three-year Parkinson's research partnership will examine whether cells from menstrual blood, placentas and umbilical cords could support new therapies. The collaboration brings together the University of Sheffield's Sheffield Institute for Translational Neuroscience, known as SITraN, and Liverpool-based cell therapy manufacturer BioGrad. The research project is being led by Professor Heather Mortiboys and [...]

  • Traffic noise may increase Parkinson’s risk, study suggests

    Long-term traffic noise exposure may raise Parkinson’s risk, while having a quieter side of the home could offer some protection, research suggests. Ongoing road noise was linked to a higher likelihood of developing the neurodegenerative condition. The findings suggest sleep disruption and stress throughout the body may help explain the link, although the study does [...]

  • Stamp-sized tear sensor could detect Parkinson’s disease before symptoms appear

    A stamp-sized tear sensor could help detect Parkinson’s disease before major symptoms appear, researchers say. The device is designed to detect dopamine, a brain chemical involved in movement, motivation and mood, using only a person’s tears. The findings suggest tears could offer a needle-free way to help identify Parkinson’s disease and other conditions linked to [...]

  • Gut bacteria’s vitamin B6 production may help boost dopamine in Parkinson’s

    Vitamin B6 made by gut bacteria may help nerve cells in the brain produce dopamine, according to animal research into Parkinson’s disease. Tests in worms and mice found that bacteria producing the vitamin may help cells make dopamine, a chemical involved in motor control that is lacking in Parkinson’s. Giving vitamin B6 to mice that [...]

  • Disease-modifying trials overtake symptom management in Parkinson’s research for first time, analysis finds

    The most comprehensive analysis yet undertaken of Parkinson's drug trials has found that research aimed at slowing or stopping the condition now accounts for the majority of new trials, overtaking symptom management for the first time in the history of the field. The study, published in the Journal of Parkinson's Disease, was carried out by [...]

  • First-ever stem-cell brain transplant for Parkinson’s passes major safety test

    A stem-cell brain transplant for Parkinson’s has passed an initial safety test after eight patients received the treatment. No serious side effects linked to the transplanted cells were recorded during the first year of follow-up. The treatment aims to replace dopamine-producing nerve cells lost through Parkinson’s disease, potentially addressing the underlying damage rather than only [...]